Pharmacokinetic evaluation, molecular docking and in vitro biological evaluation of 1, 3, 4-oxadiazole derivatives as potent antioxidants and STAT3 inhibitors

Pharmacokinetic evaluation, molecular docking and in vitro biological evaluation of 1, 3, 4-oxadiazole derivatives as potent antioxidants and STAT3 inhibitors

1, 3, 4-Oxadiazole derivatives (4a–5f) were previously synthesized to investigate their anticancer properties. However, studies relating to their antioxidant potential and signal transducer and activator of transcription (STAT) inhibition have not been performed. We investigated previously synthesiz...

Full description

Bibliographic Details
Main Authors:	Rashmin khanam, Iram I. Hejazi, Syed Shahabuddin, Abdul R. Bhat, Fareeda Athar
Format:	Article
Language:	English
Published:	Elsevier 2019-04-01
Series:	Journal of Pharmaceutical Analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095177918305082

Similar Items

Synthesis, docking and biological evaluation of thiadiazole and oxadiazole derivatives as antimicrobial and antioxidant agents
by: Zabiulla, et al.
Published: (2020-01-01)

Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study
by: Ahmed, QU, et al.
Published: (2019)

Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study
by: Ahmed, Q.U, et al.
Published: (2019)

Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1, 3, 4-oxadiazole-based compounds
by: Farshid Hassanzadeh, et al.
Published: (2020-01-01)

Molecular Docking, Computational, and Antithrombotic Studies of Novel 1,3,4-Oxadiazole Derivatives
by: Majda Batool, et al.
Published: (2018-11-01)

Hypoglycemic, hepatoprotective and molecular docking studies of 5-[(4-chlorophenoxy) methyl]-1, 3, 4-oxadiazole-2-thiol
by: Naureen Shehzadi, et al.
Published: (2018-05-01)

Anti-Inflammatory, Analgesic Evaluation and Molecular Docking Studies of N-Phenyl Anthranilic Acid-Based 1,3,4-Oxadiazole Analogues
by: Suman Bala, et al.
Published: (2013-01-01)

Novel 1,3,4-oxadiazole Targets STAT3 Signaling to Induce Antitumor Effect in Lung Cancer
by: Vikas H. Malojirao, et al.
Published: (2020-09-01)

Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison
by: Ulviye Acar Çevik, et al.
Published: (2020-01-01)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
by: Agata Zięba, et al.
Published: (2021-06-01)

Synthesis, characterization and pharmacological evaluation of (Z)-2-(5-(biphenyl-4-yl)-3-(1-(imino)ethyl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)phenol derivatives as potent antimicrobial and antioxidant agents
by: Manav Malhotra, et al.
Published: (2017-02-01)

Discovery of Novel 1,2,4-Oxadiazole Derivatives as Potent Caspase-3 Activator for Cancer Treatment
by: Ankur Vaidya
Published: (2021-03-01)

Synthesis, characterization and antibacterial activity of novel poly(silyl ether)s based on palm and soy oils
by: Issam Ahmed Mohammed, et al.
Published: (2018-11-01)

Design, synthesis and biological evaluation of 1,3,4-oxadiazoles/thiadiazoles bearing pyrazole scaffold as antimicrobial and antioxidant candidates
by: Pavithra Gurunanjappa, et al.
Published: (2016-07-01)

Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives
by: Camelia Elena Stecoza, et al.
Published: (2021-05-01)

Tyrosinase Inhibitory Activity, 3D QSAR, and Molecular Docking Study of 2,5-Disubstituted-1,3,4-Oxadiazoles
by: Ramesh L. Sawant, et al.
Published: (2013-01-01)

Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
by: Malgorzata Szelag, et al.
Published: (2015-01-01)

Synthesis of New 1, 3, 4-Oxadiazole-Incorporated 1, 2, 3-Triazole Moieties as Potential Anticancer Agents Targeting Thymidylate Synthase and Their Docking Studies
by: Mohammad Mahboob Alam, et al.
Published: (2020-11-01)

Ultrasound- and Molecular Sieves-Assisted Synthesis, Molecular Docking and Antifungal Evaluation of 5-(4-(Benzyloxy)-substituted phenyl)-3-((phenylamino)methyl)-1,3,4-oxadiazole-2(3H)-thiones
by: Urja D. Nimbalkar, et al.
Published: (2016-05-01)

Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
by: Byung-Hak Kim, et al.
Published: (2019-11-01)

Synthesis and evaluation of antimicrobial activity of novel 1,3,4-oxadiazole derivatives
by: Popat B. Mohite, et al.
Published: (2011-09-01)

Syntheses, Evaluation and Characterization of Some 1, 3, 4-Oxadiazoles as Antimicrobial Agents
by: Niti Bhardwaj, et al.
Published: (2009-01-01)

Synthesis, biological evaluation and docking studies of 1,2,4-oxadiazole linked 5-fluorouracil derivatives as anticancer agents
by: Ravi Kumar Bommera, et al.
Published: (2021-05-01)

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
by: Maryam Aftabizadeh, et al.
Published: (2021-01-01)

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
by: Song Wu, et al.
Published: (2018-08-01)

Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles
by: Aliya Ibrar, et al.
Published: (2018-03-01)

Molecular docking and biological evaluation of some thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and anticonvulsant agents
by: Danah S. Al-Shamary, et al.
Published: (2017-05-01)

4-[4-(4-Amino-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine
by: Ping Li, et al.
Published: (2012-05-01)

3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazole
by: Philip Pagoria, et al.
Published: (2014-05-01)

Biological Evaluation and Docking Analysis of Potent BACE1 Inhibitors from Boesenbergia rotunda
by: Kumju Youn, et al.
Published: (2019-03-01)

Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors
by: Xiao-Yan Jin, et al.
Published: (2019-01-01)

Synthesis of Novel Oxadiazole Derivatives, Molecular Properties Prediction and Molecular Docking Studies
by: Zühal Kılıç Kurt
Published: (2020-10-01)

Discovery of C-3 Tethered 2-oxo-benzo[1,4]oxazines as Potent Antioxidants: Bio-Inspired Based Design, Synthesis, Biological Evaluation, Cytotoxic, and in Silico Molecular Docking Studies
by: Vashundhra Sharma, et al.
Published: (2018-03-01)

Development of Predictive Antioxidant Models for 1,3,4-Oxadiazoles by Quantitative Structure Activity Relationship
by: Ikechukwu Alisi, et al.
Published: (2019-06-01)

Design, Synthesis, and Cytotoxic Evaluation of Etodolac-1,3,4-oxadiazole-1,2,3-triazole Molecules
by: Bhaskar Kummari, et al.
Published: (2018-01-01)

Drug-1,3,4-Thiadiazole Conjugates as Novel Mixed-Type Inhibitors of Acetylcholinesterase: Synthesis, Molecular Docking, Pharmacokinetics, and ADMET Evaluation
by: Rabail Ujan, et al.
Published: (2019-02-01)

Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.
by: Hatem A Abuelizz, et al.
Published: (2019-01-01)

Synthesis, biological evaluation and molecular docking analysis of vaniline–benzylidenehydrazine hybrids as potent tyrosinase inhibitors
by: Aida Iraji, et al.
Published: (2020-04-01)

Triazoloquinazolines as a new class of potent alpha-glucosidase inhibitors: in vitro evaluation and docking study
by: Abuelizz, HA, et al.
Published: (2019)

Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: In vitro evaluation and docking study
by: Abuelizz, H.A, et al.
Published: (2019)